1. Home
  2. KRKR vs CDIO Comparison

KRKR vs CDIO Comparison

Compare KRKR & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 36Kr Holdings Inc.

KRKR

36Kr Holdings Inc.

N/A

Current Price

$3.00

Market Cap

5.6M

ML Signal

N/A

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

N/A

Current Price

$2.04

Market Cap

5.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRKR
CDIO
Founded
2010
2017
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRKR
CDIO
Price
$3.00
$2.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.0K
36.8K
Earning Date
03-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,825.00
Revenue This Year
N/A
$171,906.75
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.97
52 Week High
$21.36
$7.91

Technical Indicators

Market Signals
Indicator
KRKR
CDIO
Relative Strength Index (RSI) 57.27 61.98
Support Level $2.84 $1.68
Resistance Level $3.25 $2.16
Average True Range (ATR) 0.22 0.16
MACD 0.04 0.06
Stochastic Oscillator 71.21 68.67

Price Performance

Historical Comparison
KRKR
CDIO

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in the PRC.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: